J Drugs Dermatol. 2023 Mar 1;22(3):300-301. doi: 10.36849/JDD.7161.
Novel coronavirus SARS-CoV-2, designated as COVID-19 by the World Health Organization (WHO) on February 11, 2020, is one of the highly pathogenic β-coronaviruses that infects humans.1 Alopecia areata (AA) is a chronic inflammatory disease with sudden hair loss.2,3 There is strong evidence that AA is a tissue-specific autoimmune disease that develops based on genetic predisposition.4 In several patients, acute or chronic psycho-emotional stress may be causing the initiation and/or progress of AA.5 It is suggested that psychological stress can trigger or exacerbate inflammatory skin diseases through the neuroendocrine system, which is an essential connection between the brain and the skin.6,7 Hair loss has emerged as a frequently noted side effect of infection with COVID-19, and has been observed in many patients who have recovered from a documented COVID-19 illness.8,9.
新型冠状病毒 SARS-CoV-2,世界卫生组织(WHO)于 2020 年 2 月 11 日命名为 COVID-19,是感染人类的高致病性β冠状病毒之一。1 斑秃(AA)是一种突发性脱发的慢性炎症性疾病。2,3 有强有力的证据表明,AA 是一种基于遗传易感性发展的组织特异性自身免疫性疾病。4 在一些患者中,急性或慢性心理情绪压力可能导致 AA 的起始和/或进展。5 有人认为,心理压力可以通过神经内分泌系统引发或加重炎症性皮肤病,这是大脑和皮肤之间的重要联系。6,7 脱发已成为感染 COVID-19 的常见副作用,并在许多从有记录的 COVID-19 疾病中康复的患者中观察到。8,9